Acrivon Therapeutics (ACRV) announced the appointment of Ivana Magovcevic-Liebisch, Ph.D., J.D., to its board of directors. Dr. Magovcevic-Liebisch is the president and chief executive officer at Vigil Neuroscience (VIGL).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ACRV:
- Acrivon Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Acrivon Therapeutics appoints Cuillerot as Chief Medical Officer
- Acrivon Therapeutics assumed with a Buy at Jefferies
